Corcept Therapeutics Expands Executive Team; Atabak Mokari Joins As Chief Financial Officer; Charles Robb Named Chief Business Officer
March 01, 2021 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
$4.17 Billion Engineered T Cells Markets - Global Market Forecast Report 2021-2025
February 11, 2021 07:03 ET
|
Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Engineered T Cells Market Research Report by Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has been added to...
Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
January 28, 2021 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that the...
Outlook on the CAR-T Cell Therapy Global Market to 2027 - Capitalize on Emerging Trends
January 05, 2021 06:33 ET
|
Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials and Trends, 2021" report has been added to ResearchAndMarkets.com's offering. ...
Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603
December 10, 2020 07:30 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced enrollment...
Insights on the CAR T-Cell Therapy Global Market to 2030 - Potential Opportunities for Immunotherapy
December 09, 2020 05:28 ET
|
Research and Markets
Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "Global CAR T-Cell Therapy Market: Focus on Product, Mechanism, Application, Target Antigen, Country Data (14 Countries), and Competitive Landscape -...
Triax Technologies Named to Inc.’s Best in Business List for IoT Solution Helping Companies Minimize COVID-19 Risk in the Workplace
December 08, 2020 12:43 ET
|
Triax Technologies
NORWALK, Conn., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Triax Technologies, Inc., a leading Internet of Things (IoT) worksite platform provider connecting construction, energy, manufacturing and...
Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
December 07, 2020 07:30 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that it has...
Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update
November 05, 2020 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
Strategic focus on clinical GoCAR-T® programs with plans to initiate Phase 1/2 enrollment of BPX-601 in mCRPC and BPX-603 in HER2+ solid tumors by end of year Completed offering of shares of common...
Bellicum Pharmaceuticals Announces Closing of $25.0 Million Underwritten Offering
November 03, 2020 20:26 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced the closing...